TY  - JOUR

T1  - Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT

JO  - Health Technology Assessment

PY  - -0001/11/30

AU  - Hykin P

AU  - Prevost AT

AU  - Sivaprasad S

AU  - Vasconcelos JC

AU  - Murphy C

AU  - Kelly J

AU  - Ramu J

AU  - Alshreef A

AU  - Flight L

AU  - Pennington R

AU  - Hounsome B et al

ED  - 

PB  - NIHR Journals Library

Y2  - 2024/09/19

ER  -